Clinical Trial Update: VISSIT Intracranial Stent Study for Ischemic Therapy [Phase 2, Phase 3]

View source ↗

Summary

The VISSIT intracranial stent study for ischemic stroke and transient ischemic attack in Phase 2/3 was terminated. Results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Stroke
• Transient Ischemic Attack

Drugs mentioned

• VISSIT Intracranial Stent

Snippet

Sponsor: Codman & Shurtleff | Conditions: Ischemic Stroke, Transient Ischemic Attack | Phase 2, Phase 3 | Status: TERMINATED | Results posted: 2014-06-16